These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27382386)

  • 1. Breast Cancer Mortality among Asian-American Women in California: Variation according to Ethnicity and Tumor Subtype.
    Parise C; Caggiano V
    J Breast Cancer; 2016 Jun; 19(2):112-21. PubMed ID: 27382386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparities in the risk of the ER/PR/HER2 breast cancer subtypes among Asian Americans in California.
    Parise C; Caggiano V
    Cancer Epidemiol; 2014 Oct; 38(5):556-62. PubMed ID: 25172158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in clinicopatholgic characteristics and risk of mortality between the triple positive and ER+/PR+/HER2- breast cancer subtypes.
    Parise CA; Caggiano V
    Cancer Causes Control; 2019 May; 30(5):417-424. PubMed ID: 30879205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004.
    Parise CA; Bauer KR; Brown MM; Caggiano V
    Breast J; 2009; 15(6):593-602. PubMed ID: 19764994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-specific incidence of breast cancer subtypes: understanding the black-white crossover.
    Clarke CA; Keegan TH; Yang J; Press DJ; Kurian AW; Patel AH; Lacey JV
    J Natl Cancer Inst; 2012 Jul; 104(14):1094-101. PubMed ID: 22773826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of cancer-specific, cardiovascular, and all-cause mortality among Asian and Pacific Islander breast cancer survivors in the United States, 1991-2011.
    Solanki PA; Ko NY; Qato DM; Calip GS
    Springerplus; 2016; 5():82. PubMed ID: 26844029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry.
    Telli ML; Chang ET; Kurian AW; Keegan TH; McClure LA; Lichtensztajn D; Ford JM; Gomez SL
    Breast Cancer Res Treat; 2011 Jun; 127(2):471-8. PubMed ID: 20957431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of mortality of node-negative, ER/PR/HER2 breast cancer subtypes in T1, T2, and T3 tumors.
    Parise CA; Caggiano V
    Breast Cancer Res Treat; 2017 Oct; 165(3):743-750. PubMed ID: 28689363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in breast cancer subtypes with age and race/ethnicity.
    Parise CA; Bauer KR; Caggiano V
    Crit Rev Oncol Hematol; 2010 Oct; 76(1):44-52. PubMed ID: 19800812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer-specific survival by clinical subtype after 7 years follow-up of young and elderly women in a nationwide cohort.
    Johansson ALV; Trewin CB; Hjerkind KV; Ellingjord-Dale M; Johannesen TB; Ursin G
    Int J Cancer; 2019 Mar; 144(6):1251-1261. PubMed ID: 30367449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Influence of Socioeconomic Status on Racial/Ethnic Disparities among the ER/PR/HER2 Breast Cancer Subtypes.
    Parise CA; Caggiano V
    J Cancer Epidemiol; 2015; 2015():813456. PubMed ID: 26339244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors associated with the triple-negative breast cancer subtype within four race/ethnicities.
    Parise CA; Caggiano V
    Breast Cancer Res Treat; 2017 May; 163(1):151-158. PubMed ID: 28213780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment and survival disparities by ethnicity in New Zealand women with stage I-III breast cancer tumour subtypes.
    Lawrenson R; Lao C; Campbell I; Harvey V; Seneviratne S; Edwards M; Elwood M; Scott N; Kidd J; Sarfati D; Kuper-Hommel M
    Cancer Causes Control; 2017 Dec; 28(12):1417-1427. PubMed ID: 29027594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease characteristics and mortality among Asian women with breast cancer.
    Yu AYL; Thomas SM; DiLalla GD; Greenup RA; Hwang ES; Hyslop T; Menendez CS; Plichta JK; Tolnitch LA; Fayanju OM
    Cancer; 2022 Mar; 128(5):1024-1037. PubMed ID: 34792814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast Cancer Outcomes as Defined by the Estrogen Receptor, Progesterone Receptor, and Human Growth Factor Receptor-2 in a Multi-ethnic Asian Country.
    Subramaniam S; Bhoo-Pathy N; Taib NA; Tan GH; See MH; Jamaris S; Ho GF; Looi LM; Yip CH
    World J Surg; 2015 Oct; 39(10):2450-8. PubMed ID: 26138872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial/Ethnic Disparities in Survival after Breast Cancer Diagnosis by Estrogen and Progesterone Receptor Status: A Pooled Analysis.
    John EM; McGuire V; Kurian AW; Koo J; Shariff-Marco S; Gomez SL; Cheng I; Keegan THM; Kwan ML; Bernstein L; Vigen C; Wu AH
    Cancer Epidemiol Biomarkers Prev; 2021 Feb; 30(2):351-363. PubMed ID: 33355191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Socioeconomic status and incidence of breast cancer by hormone receptor subtype.
    Akinyemiju TF; Pisu M; Waterbor JW; Altekruse SF
    Springerplus; 2015; 4():508. PubMed ID: 26405628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing breast cancer incidence and trends among Asian American, Native Hawaiian, and non-Hispanic White women in Hawai'i, 1990-2014.
    Ihenacho U; McKinley MA; Vu A; Hernandez BY; Loo LWM; Gomez SL; Wu AH; Cheng I
    Cancer Causes Control; 2023 Mar; 34(3):241-249. PubMed ID: 36504334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Family history of breast cancer in first-degree relatives and triple-negative breast cancer risk.
    Phipps AI; Buist DS; Malone KE; Barlow WE; Porter PL; Kerlikowske K; Li CI
    Breast Cancer Res Treat; 2011 Apr; 126(3):671-8. PubMed ID: 20814817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast Cancer Subtype as a Predictor of Lymph Node Metastasis according to the SEER Registry.
    Mattes MD; Bhatia JK; Metzger D; Ashamalla H; Katsoulakis E
    J Breast Cancer; 2015 Jun; 18(2):143-8. PubMed ID: 26155290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.